List view / Grid view
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By European Pharmaceutical Review
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
21 February 2019 | By Telstar
The pharmaceutical industry is increasingly using different sterilisation technologies rather thansteam sterilisation. This increase is driven by the need for sterilizing thermo-labile products orareas that cannot be dimensioned as a pressure vessel (barrier systems such as Closed Restricted Access Areas or Isolators), under “softer” conditions.
20 February 2019 | By European Pharmaceutical Review
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
20 February 2019 | By European Pharmaceutical Review
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
19 February 2019 | By European Pharmaceutical Review
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
19 February 2019 | By European Pharmaceutical Review
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
18 February 2019 | By European Pharmaceutical Review
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment...
18 February 2019 | By European Pharmaceutical Review
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...
18 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
15 February 2019 | By European Pharmaceutical Review
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
15 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
14 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A collaboration between Brigham and Women's Hospital and Vanderbilt University Medical Center looks to advance the application of AI in health...
14 February 2019 | By European Pharmaceutical Review
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
13 February 2019 | By European Pharmaceutical Review
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
Follow: